EBM時代の心房細動　25のエッセンス

出版社： メディカルサイエンス社
著者：
発行日： 2010-11-25
分野： 臨床医学：内科  >  血管
ISBN： 9784903843100
電子書籍版： 2010-11-25 （第1版第3刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

3,080 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,464 円(税込)

購入する

商品紹介

“ Keep It Simple”という山下氏独自の視点から、心房細動診療のコンセプトを明確にした本。心房細動診療のここまでの変化を、20年前に誰が予想できただろうか？ 本書では、その歴史を象徴する25のKey Evidenceを紹介、時代時代のKeywordを軸に「心房細動診療の“これまで”と“これから”」に鋭く斬り込む。疾患の歴史から紐解くという新しいアプローチで、ぶれることのない心房細動診療の「芯」が見えてくるかもしれない。

目次

  • EBM時代の心房細動　25のエッセンス

    ―目次―

    第?章
    心電図指標がメルクマール：
    1990年前後〜

    第II章
    Mortality とMorbidityへの転換期：
    2000 年頃〜

    第III章
    トータルマネジメントの時代へ：
    現在〜

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

序章 心房細動治療の歴史を振り返り、新たな道を探る

P.6 掲載の参考文献
1) Harvey W. Exercitatio anatomica de motu codis et sanguinis in animalibus. Movement of the heart and blood in animals ; translated by KJ Franklin. Oxford : Blackwell, 1957.
 
2) Burns A. Observations on formation of polypi of the heart. In : Diseases of the Heart, Edinburgh, Bryce, 1809.
 
3) Lip GY, Beevers DG. ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation. BMJ 1995 ; 311(7016) : 1361-1363.
PubMed
4) Hoffa M, et al. Einige neuve versuche uber Herzebewgung. Z Rationelle Med 1850 ; 9 : 107-144.
 
5) Marey EJ. Physiologie medicine de las Circulation du Sang. Paris, 1863.
 
6) Vulpian A. Note sur les effets de la faradisation directe des ventricules du coeur le chien. Arch de Physiol 1874 ; i : 975.
 
7) MacWilliam JA. Fibrillar contraction of the heart. J Physiol 1887 ; 8 : 296.
 
8) Hering HE. Analyse des Pulsus irregularis. Prag med Wochenschr 1903 ; 28 : 377-381.
 
9) Einthoven W. Die galbanometrische Registerierung des menshlichen Electrokardiogramms, zugleicheine Beurteilung der Anvendung des Kapillar-Electrometers in der Anvendung des Kapillar-Electrometers in der Physiologie. Pflugers Arch 1903 ; 99 : 472.
 
10) Hering HE. Das Elektokardiogramme des Irregularis perpetuus. Deutsch Archiv f klin Med 1908 ; XCIV ; 205-208.
 
11) Lewis T. Auricular fibrillation ; a common clinical condition. Br Med J 1909 ; 2 : 1528.
PubMed
12) Rothberger CJ, Winterberg H. Vorhofflimmern und Arhythmia perpetua. Wien Klin Wochenschr. 1909 ; 22 : 839-844.
 
13) Robinson GC. The Influence of the Vagus Nerves on the Faradized Auricles in the Dog's Heart. J Exp Med 1913 ; 17 : 429-443.
 
14) Lewis T. The Mechanism and Graphic Registration of Heart. 3 ed. London, Show and Sons, 1925.
 
15) Weiss S, et al. Rheumatic heart disease. III. Embolic manifestations. Am Heart J 1933 ; 9 : 45-52.
 
16) Scherf D. Studies on auricular tachycardia caused by aconitine administration. Pro Soc Exp Biol Med 1947 ; 64 : 293-239.
 
17) White PD. Atrial fibrillation. Heart Disease 1950 ; 893-912.
 
18) Katz LN. The importance of cardiac arrhythmias. Bull N Y Acad Med 1952 ; 28 : 294-306.
PubMed
19) Aberg H. Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta Med Scand 1969 ; 185 : 373-379.
 
20) Vaughan Williams EM. The experimental basis for the choice of an anti-arrhythmic drug. Adv Cardiol 1970 ; 4 : 275-289.
PubMed
21) Fisher CM. Treatment of chronic atrial fibrillation. Lancet 1972 ; 1 : 1284.
PubMed
22) Harrison DC, et al. Ambulatory electrocardiography for diagnosis and treatment of cardiac arrhythmias. N Engl J Med 1976 ; 294 : 373-380.
PubMed
23) Task Force of the Working Group on Arrhythmias of the European Society of Cardiology : The Sicilian Gambit : A new approach to the classification of antiarrhythmic drugs based on their action on arrhythmogenic mechanisms. Circulation 1991 ; 84 : 1831-1851.
 
24) Allessie MA, et al. Nonlinear analysis of epicardial atrial electrograms of electrically induced atrial fibrillation in man. J Cardiovasc Electrophysiol 1995 ; 6 : 419-440.
 
25) Bruins P, et al. Activation of the complement system during and after cardiopulmonary bypass surgery : postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997 ; 96 : 3542-3548.
PubMed
26) Frustaci A, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997 ; 96 : 1180-1184.
PubMed
27) Members of the Sicilian Gambit. New Approaches to Antiarrhythmic Therapy, Part II : Emerging Therapeutic Applications of the Cell Biology of Cardiac Arrhythmias. Circulation 2001 ; 104 : 2990-2994.
 
28) Allessie MA, et al. Importance of right and left atrial dilation and linear ablation for perpetuation of sustained atrial fibrillation. J Cardiovasc Electrophysiol 2002 ; 13 : 164-171.
PubMed
29) de Senac JB. Traite de la structure du coeur, de son action, et de ses maladies. 2nd ed., vol.II. Paris : Mequignon l'aine ; 1783.
 
30) Withering W. An account of the foxglove and some of its medical uses ; with practical remarks on the dropsy, and some other diseases, Publ Swinney, Birmingham, 1785.
 
31) Bouillaud J. Traite clinique des Maladies du Coeur. Paris. JB Bailliere, 1835, 141-142.
 
32) Mackenzie J. Digitalis. Heart 1911 ; 2 : 273-389.
 
33) Wenckebach KF. Die Unregalmassign Herztatigkeit Und Ihre Klinische Bedeutung. Leipzig, W Englemann, 1914.
 
34) Frey W. Ueber das Vorhofflimmern beim Menschen und seine Beseitigung durch Chinidin. Berl klin Wochenschr 1918 ; 18 : 417-419, 450-452.
 
35) Clark-Kennedy AE. Quinidine in the treatment of auricular fibrillation. Q J Med 1922 ; 16 : 205.
 
36) Lown B, et al. Cardioversion of atrial fibrillation : A report on the treatment of 65 episodes in 50 patients. N Engl J Med 1963 ; 269 : 325-331.
PubMed
37) Cox JL, et al. Modification of the maze procedure for atrial flutter and atrial fibrillation. I. Rationale and surgical results. J Thorac Cardiovasc Surg 1995 ; 110 : 473-484.
PubMed
38) Gaita F, et al. Radiofrequency catheter ablation of accessory pathways : a contemporary review. J Cardiovasc Electrophysiol 1994 ; 5 : 532-552.
PubMed
39) Haissaguerre M, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998 ; 339 : 659-666.
PubMed
40) Haissaguerre M, Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 2000 ; 101 : 1409-1417.
PubMed
41) 加藤和三. 治療の歴史-抗心房細動薬. 治療学 2009 ; 43 : 109-115
 
42) Kannel WB, et al. Epidemiologic features of chronic atrial fibrillation : the Framingham study. N Engl J Med 1982 ; 306 : 1018-1022.
PubMed
43) van den Berg MP, et al. Analysis of heart rate variability in a patient with paroxysmal atrial fibrillation. Eur Heart J 1995 ; 16 : 2011-2012.
 
44) Beta-Blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 2001 ; 344 : 1659-1667.
 
45) Madrid AH, et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation : a prospective and randomized study. Circulation 2002 ; 106 : 331-336.
PubMed
46) Young-Xu Y et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 2003 ; 92 : 1379-1383.
PubMed
47) Madrid AH, et al. The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases : meta-analysis of randomized controlled clinical trials. Pacing Clin Electrophysiol 2004 ; 27 : 1405-1410.
 

第I章 心電図指標がメルクマール : 1990年前後～

P.20 掲載の参考文献
1) Guidelines for the management of atrial fibrillation : The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010 Aug 29. [Epub ahead of print]
 
2) Kazunori Toyoda, et al. Dual Antithrombotic Therapy Increases Severe Bleeding Events in Patients With Stroke and Cardiovascular Disease A Prospective, Multicenter, Observational Study. Stroke 2008 ; 39 ; 1740-1745.
PubMed

第II章 Mortality とMorbidityへの転換期 : 2000年頃～

P.50 掲載の参考文献
1) Talajic M, et al. AF-CHF Investigators. Maintenance of sinus rhythm and survival in patients with heart failure and atrial fibrillation. J Am Coll Cardiol 2010 ; 55 : 1796-1802.
PubMed
2) de Vos CB, et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol 2010 ; 55 : 725-731.
PubMed

View Point

P.70 掲載の参考文献
1) Lip GY, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach : the Euro Heart Survey on atrial fibrillation. Chest 2010 ; 137 : 263-272.
PubMed
2) Pisters R, et al. A novel userfriendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients : The Euro Heart Survey. Chest 2010 ; March 18 [Epub ahead of print].
 
3) 心房細動治療 (薬物) ガイドライン (2008年改訂版). Circ J 2008 ; 72 (Suppl. IV) : S1581-S1638.
 
4) Connolly SJ, et al. the RE-LY steering committee and investigators : Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009 ; 361 : 1139-1151.
 

書評

最近チェックした商品履歴

Loading...